Market Insights Snapshot
In Alberta, Ovis has shown a strong performance in the Capsules category, moving from the 6th position in July 2023 to consistently holding the 2nd spot in both September and October 2023. This upward trend suggests a growing consumer preference for Ovis' Capsules in this market. However, in the Edibles category, Ovis' ranking was not among the top 20 in October 2023, indicating a less competitive position in this segment compared to Capsules.
Turning our attention to Saskatchewan, Ovis' performance in the Capsules category has been somewhat fluctuating. The brand moved up from the 7th spot in July 2023 to the 3rd in August 2023, but then fell back to the 6th position in September and October 2023. Despite this, Ovis has consistently remained within the top 10 brands in this category, suggesting it still holds a strong position in the Saskatchewan market. Sales data also points to a general upward trend, although the exact figures will be reserved for more in-depth analysis.
In the Capsules category in Alberta, Ovis has shown a significant upward trend, improving its rank from 6th place in July 2023 to consistently holding 2nd place in September and October 2023. This advancement in rank has seen Ovis surpass competitors like Dosecann and Frank, both of which have seen a decrease or stagnation in their ranks over the same period. However, Ovis still trails behind the market leader, Stigma Grow, which has consistently held the 1st place rank. In terms of sales, Ovis has seen a steady increase, indicating a growing market share, although it still falls short of its competitors' sales volumes. The missing ranks for some brands indicate that they were not in the top 20 brands for the Capsules category in Alberta during those months.
In October 2023, Ovis' top-performing product was the 'CBD:THC 10:10 Balanced Softgel 15-Pack (150mg CBD, 150mg THC)' with the highest sales figure of 4698 units. This product maintained its top rank from the previous three months. The 'Blue THC Softgel 10-Pack (150mg)' was the second highest-selling product, slightly lower with 4625 units sold. Interestingly, it was the top product in July 2023 but dropped to second place from August onwards. The rankings of the 'CBD:THC 50:5 Softgels 15-Pack (750mg CBD, 75mg THC)', 'CBD Softgels 30-Pack (1500mg CBD)', and 'CBN Goftgels 10-Pack (200mg CBN)' remained consistent at third, fourth, and fifth respectively.